LKSIoV COVID-19 and Emerging Pathogens Research Fund Results
(Funding rate = 18.2%)
| INVESTIGATOR(S) | DEPARTMENT / FACULTY | PROJECT TITLE | AMOUNT |
|---|---|---|---|
| Basil Hubbard | Pharmacology; FoMD | Small-molecule inhibitors of Nsp15 for the prevention and treatment of SARS-CoV-2 | $35,000 |
| Greg Tyrrell | Laboratory Medicine & Pathology; FoMD | Developing a safe subunit vaccine for COVID-19 by using convalescent plasma to identify immunogenic epitopes | $35,000 |
| Hyo-Jick Choi | Chemical & Materials Engineering; Engineering | Virus inactivating salt‐coated mask to prevent transmission of COVID‐19 | $35,000 |
| Paul Jurasz | Pharmacy & Pharmaceutical Sciences | Angiostatin: A potential novel biomarker of COVID-19 underlying pathophysiology | $35,000 |
| Reinhard Vehring | Mechanical Engineering; Engineering | Glass stabilization of an adjuvanted subunit coronavirus vaccine via spray drying | $35,000 |
| Shokrollah Elahi | Dentistry; FoMD | Investigating the effects of dexamethasone on ACE2 expression as a therapeutic approach against SARS-CoV-19 infection | $35,000 |
| TOTAL | $210,000 |